Abstract:BACKGROUND & OBJECTIVE:In recent years, the neoadjuvant chemotherapy for cervical cancer has evoked more and more attention and has been used widely. But the chemosensitivity of individuals to various antitumor drugs is different. This study was to investigate the chemosensitivity of cervical cancer cells to antitumor drugs using in vitro MTT assay chemosensitivity test. METHODS:The sensitivity of fresh human cervical cancer cells from 32 patients to 9 cytotoxic drugs was tested using in vitro MTT assay. RESULTS:The cytotoxic activities of the 9 drugs for cervical cancer were in sequence from high to low as follows: liposomal paclitaxel, taxol, carboplatin (CBP), ifosfamide (IFO), etoposide (VP-16), 5-fluorouracil (5-FU), cisplatin (DDP), bleomycin (BLM), and cyclophosphamide (CTX). Generally, cervical cancer cells were more sensitive to paclitaxel, taxol, and CBP than to other drugs (P<0.05) with inhibition rates of 56.56%, 55.66%, and 46.81%, respectively. Stage Ib1 cervical cancer cells were more sensitive to taxol, paclitaxel, and CBP than to other drugs with inhibition rates of 58.71%, 53.00%, and 49.25%, respectively; stage Ib2 cervical cancer cells were more sensitive to paclitaxel and taxol than to other drugs with inhibition rates of 65.26% and 50.06%. Both moderately and poorly differentiated squamous cell cancer cells were more sensitive to taxol, paclitaxel, and CBP than to other drugs with inhibition rates of 52.01%, 49.21%, and 40.02% for the former, and 60.02%, 61.16%, and 48.75% for the latter. CONCLUSIONS:MTT assay, a sensitive and widely used chemosensitivity testing method, is helpful in sensitive drug screening and neoadjuvant chemotherapy regimen selection for cervical cancer. Cervical cancer cells are more sensitive to paclitaxel, taxol, and CBP than to other tested drugs in this study.

Studies of evaluable criteria for in vitro chemosensitivity using MTT assay in human breast cancer cells

Clinical Study on Sensitivity of Oral and Maxillofacial Cancers with Chemotherapy

An Evaluation of the Sensitivity of Chemotherapeutical Agents to Breast Cancer by MTT Assay in Vitro

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

Study on Chemosensitivity of Peripheral Blood Lymphocytes and Tumor Cells of Tumor Patients in Vitro

[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].

MTT measuring drug sensitivity of cancer cells and its relationship with clinical prescription

Predictive Chemotherapy of Advanced Breast Cancer Directed by MTT Assay in Vitro

Chemosensitivity in vitro of 25 anti-cancer drugs to primary cultured human breast cancer cells

Detection of Chemosensitivity of Cervical Carcinoma in Vitro by MTT Assay and Its Clinical Significance

Experimental Study on the Anti - Cancer Drugs' Sensitivity in the Colormetric Assay of Cancer Cells with MTT and Its Effective Factors

In Vitro Chemosensitivity Testing of Primary and Recurrent Breast Carcinomas and Its Clinical Significance

Research and Exploratory of Chemotherapy Drugs Sensitivity Tests in Liver Cancer

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

Analysis of Drug Sensitivity and Its Guidance in Clinic in 61 Cases of Breast Cancer Cell

Study on the chemosensitivity test with TECIA in vitro for the choice of individualized chemotherapy of lung cancer

Investigation On The Sensitivities Of Single And Combined Antitumor Drugs In Vitro By Real-Time Cell Electronic Sensing Technology

PREDICTION OF SENSITIVITY ON HEPATOMA CHEMOIMMUNOTHERAPY USING MTT ASSAY

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

Study on susceptibility of eight common chemotherapy drug combinations in human cervical carcinoma cell in vitro

[Progress of Individualized Chemotherapy Guided by Chemosensitivity Test].